GLP-1 Receptor Agonists and the Reduction of Alcohol-Related Hospitalizations in Alcohol Use Disorder
New real-world evidence suggests semaglutide and tirzepatide may reduce alcohol-related hospitalizations among patients with AUD and metabolic disease, warranting further clinical trials.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.